×

Neville Registrars is delighted to welcome SWP Group plc as the newest addtion to its list of client companies.

SWP Group designs, manufactures and installs a range of industrial engineered products and systems, serving international markets in the following sectors:

• Oil, Gas and Petrochemical
• Construction
• Water Utilities

Further information can be found on the Company's website:http://www.swpgroupplc.com/

 

 

Close

×

RNS Number : 8065H

Galileo Resources PLC

22 August 2016

 

 

 

 

For immediate release

 

22 August 2016

Galileo Resources Plc

("Galileo" or "the Company")

 

Study Increases Significantly Concordia Potential Size   

 

 

Galileo (AIM: GLR), the exploration and development mining company, is pleased to announce the completion of an exploration desktop study, (previously announced near completion on 15 June 2016), which has identified and ranked seven high priority additional prospective copper targets within the Concordia Project with the potential of accommodating a significant volume of possible copper mineralised host litholigies. The study was conducted by independent multifaceted South African geological and mining consultant Minxcon Consulting (Pty) Ltd ("Minxcon"): http://www.minxcon.co.za/.

 

Highlights

 

·     An additional twenty seven prospective copper targets identified within the Concordia Project area in addition to the seven regarded as high priority targets 

 

·     The seven high priority targets present potential for shallow, near surface, open pit copper mineralised zones

 

·     The targets including those as high priority for exploration by the Company and Minxcon currently host conceptually 798.55 million host lithology tons, estimated to contain 50% mineralised host at a mean grade 0.57% Cu

 

·     All the targets studied are based on areas of existing documented and/or mapped copper occurrences that have the potential for extensions along strike and/or dip

 

·     Other identified areas are currently under investigation to increase project size potential.

 

·     Definitive Induced Polarisation (IP) geophysics to commence during 3rd quarter 2016

 

Colin Bird Chairman and CEO said "We are delighted with the progress on the Concordia project. The area is huge and our open pit model was never previously investigated in this area.  The targeted conceptual tonnage and copper grade compare very favourably with global projects currently being developed or at an advanced feasibility study stage. Other additional areas within the Concordia concession that fit our model have been identified for further investigation. The Company continues with reiterative analyses of the base data and targets consequently continue to change priority against our internal model criteria. We are highly encouraged with the results so far and the next stage exploration with IP geophysics is planned with a view to closer definition of the mineralised targets before undertaking confirmatory resource definition drilling".

 

Following on previous preliminary modelling, Minxcon conducted a desktop study on some thirty four targets to identify and rank prospective areas. Minxcon sourced additional historical data, conducted an independent re-interpretation of existing data, and identified seven prospective, copper targets within the Concordia Project with the potential of accommodating a significant volume of possible copper mineralised host lithologies. Five of the targets identified, present potential for shallow, near surface, open-pit copper mineralised zones. Minxcon has ranked these high priority targets in the order shown in Table 1 below. The Minxcon and Galileo teams grouped some selected targets based on synergies relating to coherent geological structure, geophysical anomalies and relative locality into the eastern Homeep Trend, the western Shirley Trends and the Henderson area.

 

Table 1 : High Priority Targets Identified During the Minxcon Desktop Study (a)

Project	Strike	Width	Depth	%Cu	Lith Tonnes	Cu Tonnes
	m	m	m	%	Mt	Mt
Homeep	5000	38.8	300	0.58	168.56	0.49
Koeëlkop (incl. Whytes' West)	4000	30.0	300	0.57	104.40	0.29
Henderson	1500	38.8	300	0.58	50.57	0.15
Ring Dyke	2000	38.8	300	0.58	67.43	0.19
Tweefontein	2000	38.8	300	0.58	67.43	0.19
Klondike	2000	25.0	300	0.63	43.50	0.14
Henderson North	1000	38.8	300	0.58	33.71	0.10
Shirley	5000	38.8	300	0.58	168.56	0.49
Horneman	1100	38.8	200	0.58	24.72	0.07
Kliphoog North	1300	38.8	200	0.58	29.22	0.08
Hester Maria	1800	38.8	200	0.58	40.46	0.12
Total					798.55	2.31

(a) Notes (Table 1): Copper tonnes reported equates to approximately 50% of potential host lithology being mineralised (based on current available data)

 

The above desk top study followed on from the previously announced preliminary initial modelling on the four target areas; namely Wheal Julia and Koeëlkop (announced 29 March 2016), Whyte's West (announced 13 April 2016) and Klondike with a new identified prospect Homeep East (announced  10 May 2016). The high level estimates generated previously for these four historically drilled prospects are collated in table 2 below. Of note is the low percentage of the total strike modelled (based on available historical data) against the interpreted true strike.

 

 

 

 

 

 

Table 2: The Results of the Non-Compliant Mineral Resource Estimates Conducted by Minxcon

Prospect	Cut-off Grade	Tonnes	Cu Grade	Cu Content	Metres Modelled	% Strike Modelled
	% Cu	Mt	%	Tonnes	m	%
Koeëlkop*	0.2	10.9	0.35	38,238	1,400	35
	0.35	4.2	0.51	21,205
Wheal Julia	0.2	62.6	0.44	275,459	750	37.5
	0.35	37.7	0.55	207,863
Whyte's West*	0.2	34.6	0.39	135,918	390	9.75
	0.35	15.1	0.54	81,894
Klondike	0.2	2.5	0.57	14,263	700	35
	0.35	2.1	0.63	13,141
Total	0.2	110.6	0.42	463,878	3,240	40.5
	0.35	59.1	0.55	324,103

Notes (Table 2):

*   Combined Strike Modelled  = 44.75% as in portions of the targets in question 

 

Minxcon Disclaimer: "Minxcon has ranked the targets resulting from the desktop study in table 1, based upon its perception of the data available to them at the time of the desktop study. The above tables are subject to change with the progression of exploration activities. The above targets represent areas of documented and/or mapped copper occurrences (based on existing data), or in some cases even historical mines (Henderson (Jubilee Mine), Homeep and Wheal Julia) and have the potential for extensions along strike and/or dip. The figures in the tables presented should in no way be misconstrued to represent compliant Mineral Resource estimates nor to represent the definition of a compliant Exploration Target in terms of the various Reporting Codes, as all tonnages, grades, depths and strikes are highly conceptual in nature at this stage and require the proper exploration practices in order to prove their existence or to convert them eventually to a compliant Mineral Resource."

 

General

 

Galileo has the right to earn-in a 51% beneficial interest in the Concordia copper project, by way of 51% beneficial shareholding in Shirley Hayes IPK (Pty) Ltd ("SHIP") on expenditure of ZAR10million (approximately GBP500 000) over 14 months on exploration and development. SHIP holds the copper prospecting rights to the 36,373-hectare (364 km2) Project Area in the OKiep Copper District in the Namaqualand Complex in the Northern Cape Province of South Africa.

 

Further details are available from the Company's website which details the Company's project portfolio as well as a copy of this announcement: www.galileoresources.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

ENDS

You can also follow Galileo on Twitter: @GalileoResource

 

Technical Sign-Off

Andrew Sarosi, Director of Galileo, who holds a B.Sc. Metallurgy  and M.Sc. Engineering, University of Witwatersrand and is a member of the Institute of Materials, Minerals and Mining, is a "qualified person" as defined under the AIM Rules for Companies and a competent person under the reporting standards. The technical parts of this announcement have been prepared under Andrew's supervision and he has approved the release of this announcement.

 

 

 

 

 

For further information, please contact:

 

Galileo Resources PLC Colin Bird, Chairman	Tel +44 (0) 20 7581 4477
Andrew Sarosi, Executive Director	Tel +44 (0) 1752 221937
Beaumont Cornish Limited  – Nomad   Roland Cornish/James  Biddle Beaumont Cornish ted – Nomad Roland Cornish/James Biddle	Tel +44 (0) 20 7628 3396
Beaufort Securities Limited – Broker Jon Belliss	Tel +44 (0) 20 7382 8416

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCFMGZRMZVGVZM

Close

×

RNS Number : 3595H

Tracsis PLC

17 August 2016

 

17 August 2016

Tracsis plc

("Tracsis" or the "Group")

 

North American contract win

 

Tracsis plc, a leading provider of software and services for the traffic data and transportation industry, is pleased to announce that it has signed a significant order with a North American Class 1 railroad operator for its Remote Condition Monitoring (RCM) technology, which marks the Group's first major contract in North America.

Under the terms of the agreement, the initial order comprises the outright purchase of RCM hardware units, a software licence for the Group's data aggregation and analysis tool Centrix, and various ancillary products.  The RCM units will be installed in the coming months across multiple geographic locations on the client's network.  The total order value is in excess of $0.4m and is expected to be fulfilled before the end of 2016.

The Directors continue to view the US rail industry as being the largest and most accessible growth market for the Group's RCM technology.  This latest contract win illustrates that Tracsis has the capability and product set to address this large overseas market opportunity, although the specific timing of further sales in new territories remains difficult to predict.

The Group will issue a full year end trading update on Monday 22 August 2016.

John McArthur, Chief Executive Officer, commented: 

"We are delighted to have secured this significant order with a major class 1 operator having clearly demonstrated the business case and benefits of our remote condition monitoring technology. We are hopeful that this contract will lead to a further roll out across the client's network in the fullness of time and also act as a valuable reference case with other US rail customers."

For more information please contact:

John McArthur/Max Cawthra, Tracsis plc	Tel: 0845 125 9162
Dominic Emery/Matt Lewis, Investec Bank plc	Tel: 020 7597 4000
Rebecca Sanders-Hewett / Sarah Fabietti / Sam Modlin Redleaf Communications	Tel: 0207 382 4730 Tracsis@redleafpr.com

The information communicated in this announcement is inside information for the purposes of Article 7 of the Market Abuse Regulation 9EU) No. 596/2014.

Notes to editors: 

§ The Group specialises in solving a variety of data capture, reporting and resource optimisation problems along with the provision of a range of associated professional services.

§ Tracsis' products and services are used to increase efficiency, reduce cost and improve the operational performance and decision making capabilities for clients and customers. 

§ The Company offers the following services:

–  Rail Technology & Services: Software and technology led consulting, and Remote Condition Monitoring: Industry strength software that covers a variety of asset classes working alongside consulting and related professional services across the operational and strategic planning horizon, plus Technology and reporting for critical infrastructure assets in real time, to identify problems and aid with preventative maintenance.

–  Traffic & Data Services: Collation, analytical services, and event management within traffic and pedestrian rich environments.

§ Tracsis has a blue chip client base which includes the majority of UK transport operators.  The business also works extensively with Network Rail, the Department of Transport, multiple local authorities, Silverstone, Goodwood, and a variety of large engineering/infrastructure companies.

§ The business drives growth both organically and through acquisition and has made eight acquisitions since 2008.

§ Tracsis listed on AIM in 2007 under ticker TRCS.

§ For more information visit http://www.tracsis.com

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTGGUAGRUPQGQQ

Close

×

RNS Number : 2352H

Gresham House PLC

16 August 2016

 

16 August 2016

 

Gresham House plc ("Gresham House" or "the Company")

 

(AIM: GHE)

 

Gresham House Achieves First Close of Strategic Public Equity Fund LP

 

Gresham House, the specialist asset manager, is pleased to announce the first close of the Gresham House Strategic Public Equity Fund LP (the "SPE Fund LP") with commitments, including co-investment contributions, of £24 million.  The Company has committed £1.5 million to co-invest alongside the SPE Fund LP.  As announced by Gresham House Strategic plc ("GHS") today, GHS will be co-investing £7.5m alongside the SPE Fund LP via the transfer of 3,875,969 IMImobile ordinary shares into the co-investment structure at a price of 193.5p. 

 

The SPE Fund LP means that Gresham House Asset Management's ("GHAM") strong performing Strategic Public Equity ("SPE") investment strategy is now accessible to investors who favour limited partnership structures, including private equity fund investors, family offices and ultra-high net worth individuals. The SPE Fund LP will be a sister fund to Gresham House Strategic plc with both vehicles investing and divesting in the same opportunities. GHS and the SPE Fund LP will be managed by the same investment committee and investment team led by Tony Dalwood and Graham Bird.

 

The increased size of the shared SPE mandate will enable the investment team to combine the investment capacity of GHS and the SPE Fund LP to access larger deals of greater unit size.

 

Anthony Dalwood, CEO of Gresham House, said:

 

"Launching a limited partnership vehicle is part of our approach to grow assets under management organically. I am very pleased with the initial investor demand which includes strong support from a pension fund cornerstone investor.  This is a strong endorsement for our Strategic Public Equity strategy. 

 

"The Private Equity approach to smaller quoted companies has generated a pipeline of primary growth capital opportunities alongside secondary and pre-IPO potential investments."

 

 

Enquiries:

 

Gresham House plc Anthony (Tony) Dalwood	020 3837 6270
Liberum Capital Ltd Neil Elliot Jill Li	020 3100 2000
Montfort Communications, PR Adviser Gay Collins Rory King	greshamhouse@montfort.london 0203 770 7906

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCSFEEFIFMSEIA

Close

×

RNS Number : 7346G

Genedrive PLC

10 August 2016

 

 

RNS Reach

For release: 10 August 2016

 

Genedrive® IL28B Genotyping Assay to be used in STOP-HCV-1 Clinical Trial

 

Genedrive plc (LSE: EHP), the near patient molecular diagnostics company which recently changed its name from Epistem Holdings plc, today announces that its Genedrive® point of care IL28B human genotyping test will be used in the STOP-HCV-1 clinical trial being run by STOP-HCV, a consortium designed to use stratified medicine to optimise the treatment of patients with Hepatitis C Virus infection. The trial is designed to assess the effectiveness of different treatment durations with Direct Acting Antiviral (DAA) treatments on Hepatitis C (HCV) genotype 1 patients (http://www.stop-hcv.ox.ac.uk/stop-hcv-1-trial).

 

Direct Acting Antiviral (DAA) treatments are a new range of drugs which are replacing interferon and other established treatments for HCV. The new DAA treatments regimens are of a shorter duration (12 weeks or less), are well tolerated and offer a much improved chance of cure than earlier treatments. However, costs remain high and, at present, there are no molecular diagnostic tests to predict patients' response to treatment.

 

The STOP-HCV-1 clinical trial will assess two NICE approved DAA treatment combinations and whether the addition of another, older drug (ribavirin) has value in short course treatment. The project is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership. Around 400 patients are expected to be recruited during 2016 and 2017. The aim is to discover which patients may be cured by shorter courses of therapy and how new techniques in molecular diagnostics, including the Genedrive® IL28B point of care test, may be used to predict patient response. Genedrive will provide 20 Genedrive® units and 400 tests for use in the trial.

 

The Genedrive® test produces results within 50 minutes from a simple cheek (buccal) swab compared to the standard approach which uses a blood sample and which can have a service lab return time of 2-3 weeks for results. A recent clinical trial showed the Genedrive® IL28B test was 100% accurate at detecting genetic polymorphisms in HCV patients when compared with the current 'gold-standard' laboratory test.

 

Dr Graham Cooke, Chief Investigator of the STOP-HCV-1 clinical trial, said: "We are pleased to incorporate the Genedrive® IL28B point of care genotyping test in the STOP-HCV-1 clinical trial which aims to identify key markers to guide the duration of treatment required for HCV patients."

 

David Budd, CEO of Genedrive, commented: "The inclusion of our Genedrive® IL28B genotyping test in the STOP-HCV-1 clinical provides further validation of the potential of Genedrive® in point of care genotype diagnostic testing.

 

If the STOP-HCV-1 clinical trial demonstrates that the IL28B genotype is a reliable indication of patient response to shortened DAA treatment, we would anticipate a role for the Genedrive® IL28B test in future HCV treatments. The Genedrive® IL28B  test has been developed alongside the Genedrive® HCV test which is scheduled for market launch in 2017."

 

 

– Ends –

 

 

For further details please contact:

Genedrive plc

David Budd: CEO                                                                                                              +44 (0)161 989 0245

John Rylands: Finance Director

 

Peel Hunt LLP (NOMAD)

James Steel                                                                                                                        +44 (0)207 418 8900

Oliver Jackson

 

Consilium Strategic Communications

Chris Gardner                                                                                                                    +44 (0)203 709 5700

Matthew Neal

Laura Thornton

genedrive@consilium-comms.com 

 

 

Notes to Editors

 

Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point-of-need or point-of-care diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has been successfully assessed by the Institut Pasteur, Paris.

 

Genedrive plc was formerly Epistem plc and continues to provide contract research services to drug development companies under the Epistem brand name.

 

Further details can be found at: www.genedriveplc.com and www.genedrive.co.uk

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAAKCDQDBKBKFK

Close

×

RNS Number : 3991G

Altitude Group PLC

05 August 2016

 

Altitude Group plc

("Altitude" or the "Group")

Technology Partnership Agreement

 

Altitude Group plc, the provider of innovative technology solutions for small to medium sized businesses, is pleased to announce that its wholly owned subsidiary, Customer Focus Software Inc., has agreed a five-year agreement with Philadelphia, PA based AI Mastermind, a leading buying group serving more than 1,000 promotional product resellers representing over $200 million in annual sales in North America (the "Agreement")

Under the terms of the Agreement, Altitude will provide each AI Mastermind member with an ecommerce website that uses the Group's unique proprietary technology. Altitude will receive a share of the gross margin on all orders that are processed through the platform.

The Agreement is for an initial five-year term, with automatic renewal for a further five years. The Directors expect the first customers to be live by October 2016 and the deal to be earnings enhancing from launch.

Peter Hallett, Non-Executive Chairman of Altitude, said "AI Mastermind is one of  the fastest growing and highly respected buying groups in the $22 billion personalised product industry within the USA. This agreement further validates our decision to focus on sharing of revenue throughput. It gives Altitude access to 1,000 customers for an extremely low acquisition cost, and delivers our unique click to shiptm technology to them instantly."

Jamie Coggeshall, President and AI Mastermind, said, "We are delighted to offer this new solution to our members. We have partnered with Customer Focus on their order management solutions for the last three years and are delighted to now be able to offer this superb new ecommerce website solution that will allow our members easy access to the fastest buying channel. AI Mastermind members already enjoy incredible value for a low monthly fee and they now get the best online shopping experience in the world for no extra charge."

 

 

Enquiries:

Altitude Group plc

Peter J Hallett (Non-Executive Chairman)

Tel: 07887 987469

 

WH Ireland Limited (Nominated Adviser and Broker)

Tim Feather

Liam Gribben

Tel: 0113 394 6600

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCPAMLTMBBMMMF

Close

×

RNS Number : 1377G

APC Technology Group PLC

04 August 2016

 

4th August 2016

APC Technology Group PLC

("APC" or the "Group")

 

APC Technology Group announces Gooee Limited UK launch partnership

APC Technology Group PLC (AIM: APC), the provider of technologies and services intended to help improve organisational sustainability and specialist distributor of electronic components, has signed an agreement to be a UK partner for the launch of the Gooee Internet of Things (IoT) lighting ecosystem.

The Gooee ecosystem provides sensing, control and communication components through a scalable framework that integrates with a cloud platform to connect lighting manufacturers to the IoT.  It significantly increases control, monitoring and data analysis capabilities while driving performance and efficiency improvements.

Under the agreement APC Technology Group PLC will be able to use Gooee's new lighting ecosystem to expand its offering, providing additional functionality and value to customer lighting and IoT solutions.

Richard Hodgson, Chief Executive of APC Technology Group PLC, commented:

"I am delighted to announce our partnership with Gooee. The Gooee system puts lighting at the heart of a building's IoT, providing new opportunities to monitor LED performance, track footfall and communicate directly with occupants.

We believe these factors will be of significant interest to many of our customers, in particular those in the retail, commercial property and industrial sectors, enabling them to operate more efficiently and effectively and ultimately deliver cost savings."

Enquiries:

 

APC Technology Group PLC	01634 290 588
Leonard Seelig, Chairman Richard Hodgson, Chief Executive	www.apc-plc.co.uk
Stockdale Securities Limited (Nominated Advisor and Broker)	020 7601 6100
Mark Brown / Antonio Bossi / Edward Thomas
Redleaf Communications (Financial PR)	020 7382 4730
Rebecca Sanders-Hewett / David Ison / Susie Hudson

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRASSDFSDFMSELA

Close

×

RNS Number : 0565G

Rare Earth Minerals PLC

03 August 2016

 

Rare Earth Minerals Plc

 

("Rare Earth Minerals", "REM" or "the Company")

 

Update on Macarthur Minerals

 

Rare Earth Minerals Plc (AIM: REM; OTC: REMMY)) is pleased to report that Macarthur Minerals ("Macarthur") in which REM owns a 15.5% shareholding, has announced that the majority of its total lithium acreage of 1,489 square kilometres is expected to grant by November / December 2016. The full Macarthur announcement can be found at: http://web.tmxmoney.com/article.php?newsid=8300358548965085&qm_symbol=MMS .

McMahon Mining Title Services Report — Macarthur Minerals Lithium Licences

Macarthur Minerals retains the services of McMahon Mining Title Services ("MMTS") to manage the Company's exploration and mining licences. As detailed in Table 1, MMTS has advised the Company that 13 out of 20 of the Company's Exploration Licence Applications ("Applications") for lithium are expected to grant by November/December 2016.

The grant of exploration licences in Western Australia requires advertisement in accordance with the Mining Act 1978 (WA) ("Mining Act") and subsequent advertisement in accordance with the Native Title Act 1993 (Cth) ("Native Title Act").

All Macarthur Minerals' Applications have been advertised in accordance with the Mining Act and no objections have been maintained. Agreements have been entered into with owners of any overlapping infrastructure leases, where required. An Access Arrangement for Application E46/1115 is currently being finalised.

The majority of Macarthur Minerals' Applications are now progressing through the Native Title Act advertising period, during which, heritage agreements will be entered into with native title parties and provided no objections are raised, are expected to grant in November/December. The remaining Applications will be advertised in the near future.

Until Exploration Licences are granted, the Company will continue prospecting activities to identify exploration targets.

Iron Ore Acreage Update

In addition to Macarthur's lithium acreage, the Company has 15 granted Mining Licences and miscellaneous licences covering 140 square kilometres for its two iron ore projects located North West of Kalgoorlie in Western Australia:

·      Ularring Hematite Project consisting of Indicated 54.46 Mt @ 47.2% Fe and Inferred 25.99Mt @ 45.4% Fe3.

·      Moonshine Magnetite Project consisting of Inferred Mineral Resource consisting of 1,316 Mt @ 30.1% Fe4.

The Company has received approval to develop an iron ore mine for the Ularring Hematite Project and associated infrastructure under the Environmental Protection Act 1986 and the Environmental and Biodiversity Conservation Act 1999. There are no native title claims affecting the iron ore projects.

Table 1 — Lithium Acreage Expected Acreage Grant Timetable

	Tenement		Region		Mining Act Advertised		Native Title Advertised		Expected Grant Date1
	E45/4693		Pilbara		No objection		Yes		November
	E45/4694		Pilbara		Agreement signed		No		TBA
	E45/4702		Pilbara		No objection		Yes		November
	E45/4708		Pilbara		Agreement signed		No		TBA
	E45/4709		Pilbara		No objection		Yes		October
	E45/4710		Pilbara		No objection		Yes		October
	E45/4711		Pilbara		Agreement signed		No		TBA
	E45/4732		Pilbara		No objection		Yes		November
	E45/4735		Pilbara		Agreement signed		No		TBA
	E45/4747		Pilbara		Agreement signed		No		TBA
	E45/4748		Pilbara		Agreement signed		Yes		January
	E45/4749		Pilbara		No objection		Yes		January
	E45/4750		Pilbara		No objection		Yes		December
	E45/4779		Pilbara		Agreement signed		No		TBA
	E46/1114		Pilbara		No objection		Yes		October
	E46/1115		Pilbara		Agreement drafted		No		TBA
	E46/1133		Pilbara		No objection		Yes		November
	E59/2174		Edah		No objection		Yes		October
	E74/0587		Ravensthorpe		No objection		Yes		October
	E74/0588		Ravensthorpe		No objection		Yes		October

ABOUT MACARTHUR MINERALS LIMITED (TSX VENTURE: MMS)

Macarthur Minerals Limited is an exploration and development company that is focused on identifying and developing high grade lithium and counter cyclical investments that complement Macarthur's capabilities.

For further information, please contact:

 

Rare Earth Minerals plc                                                                     +44 (0) 207 440 0647

Andrew Suckling

Kiran Morzaria

 

WH Ireland Limited (Nomad & Broker)                                           +44 (0) 207 220 1666

James Joyce

James Bavister

 

Square1 Consulting                                                                            +44 (0) 207 929 5599

David Bick

Brian Alexander

 

Qualified Person

Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information contained in this announcement. Kiran holds a Bachelor of Engineering (Industrial Geology) from the Camborne School of Mines and an MBA (Finance) from CASS Business School.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCKMGGRNZNGVZM

Close

×

The new tax rules apply to dividend payments not interest payments. Therefore tax (currently 20%) continues to be deducted from interest payments from April 2016 onwards where applicable.

Banks and Building Societies may have special arrangements to allow interest to be paid gross.

Close

×

RNS Number : 7626F

Nanoco Group PLC

01 August 2016

 

For immediate release

1 August 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company") 

 

 

Nanoco and Merck Sign Agreement on

Eco-Friendly Quantum Materials for Displays

 

 

·      Cadmium-free quantum dots enable ultra-bright displays with a substantially extended colour range

·      Nanoco enters into a non-exclusive licence agreement with Merck, which will market Nanoco's material to its broad customer base in the display industry

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, and Merck, a leading science and technology company, today announced the signing of a worldwide material supply and licensing agreement. The licence allows Merck to immediately start marketing Nanoco's cadmium-free quantum dots and to ultimately establish its own production facility to meet growing market demand.

"The agreement is in line with Merck's strategy to sustainably secure its position as the global market and technology leader in display materials. With cadmium-free quantum dots a remarkable increase in the colour range and a significant reduction in power consumption can be achieved. These cadmium-free quantum dots are eco-friendly and also complement our product portfolio for the display industry," said Walter Galinat, member of the Merck Executive Board and CEO of Performance Materials. "The licence agreement with Nanoco will strengthen our position in quantum materials research, for which we laid the foundations by acquiring Qlight Nanotech of Israel last year."

The financial details of the agreement are not being disclosed, but Nanoco will receive a licence fee and royalties on Merck's sales of the Nanoco cadmium-free quantum dots Merck manufactures. In line with Nanoco's commercialisation strategy in the display market, this agreement is non-exclusive. Merck will begin marketing Nanoco's technology in the near term by selling cadmium-free quantum dots manufactured at Nanoco's expanded production plant in Runcorn, UK. The licence allows Merck to establish its own production facility for cadmium-free quantum dots in line with global market demand at a later point in time. Michael Edelman, Nanoco's Chief Executive Officer, added: "This agreement with Merck is another major endorsement of the world-class quality of our cadmium free quantum dot technology. We are convinced that Merck can leverage its position in the display industry with these innovative materials."

Advantages of quantum materials

Quantum materials offer a substantial additional benefit when they are used as color converters in the light source of liquid crystal displays. In conventional displays, the colors blue, green, and red are filtered out of the original white light of the LED light source. A great deal of light is lost in this process. Because a blue LED in combination with red and green quantum materials only generates the blue, green and red light that is perfectly transmitted through the filters, there is much less absorption. This increases the display's brightness, reduces electricity consumption and leads to much purer and potentially stronger colors.

 

This announcement contains inside information.

 

For further information, please contact:

 

Nanoco	Tel: +44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
David Blain, Chief Financial Officer Caroline Watson, Investor Relations Manager cwatson@nanocotechnologies.com	Tel: + 44 (0) 7799 897357
Canaccord Genuity – Joint Broker	Tel: +44 (0) 20 7523 8000
Simon Bridges Cameron Duncan
Richard Andrews
Liberum – Joint Broker	Tel: +44 (0) 20 3100 2000
Neil Patel
Richard Bootle Steven Tredget
Buchanan	Tel: +44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LC displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRKMGFNGMFGVZZ

Close